药物对比
Tirzepatide vs Sotagliflozin
比较 Tirzepatide（Mounjaro）与 Sotagliflozin（Inpefa）治疗 2 型糖尿病、肥胖和心力衰竭。双重 GIP/GLP-1 vs SGLT1/2：获益、风险，哪一种更适合您。
此页面暂无可用的对比维度。
临床背景
Patients with type 2 diabetes and coexisting obesity or heart failure often compare these two novel agents for optimal therapy selection.
结论
Neither is universally better; Tirzepatide shines in metabolic control and weight reduction while Sotagliflozin offers targeted heart failure benefits.
全部药物对比